Does BEVACIZUMAB Cause Therapy non-responder? 234 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 234 reports of Therapy non-responder have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.3% of all adverse event reports for BEVACIZUMAB.
234
Reports of Therapy non-responder with BEVACIZUMAB
0.3%
of all BEVACIZUMAB reports
33
Deaths
15
Hospitalizations
How Dangerous Is Therapy non-responder From BEVACIZUMAB?
Of the 234 reports, 33 (14.1%) resulted in death, 15 (6.4%) required hospitalization, and 8 (3.4%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 234 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which BEVACIZUMAB Alternatives Have Lower Therapy non-responder Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ